CNS & Neurological Disorders - Drug Targets (CNS-NDDT)

CNS & Neurological Disorders – Drug Targets is a peer-reviewed international journal dedicated to the discovery, characterization, and development of therapeutic agents targeting the central nervous system (CNS) and neurological disorders. The journal serves as a comprehensive platform for research in medicinal chemistry, molecular pharmacology, neuroscience, and translational medicine, with a particular focus on drug targets implicated in neurological diseases. It publishes original research articles, review papers, short communications, and clinical trial reports, covering molecular mechanisms, structure-activity relationships, pharmacokinetics, pharmacodynamics, and toxicological evaluation of neuroactive compounds. The journal emphasizes the identification and validation of novel molecular targets, including enzymes, receptors, ion channels, and signaling pathways involved in CNS pathologies. Topics include neurodegenerative diseases, neuroinflammation, neuropsychiatric disorders, stroke, epilepsy, and traumatic brain injury, with research spanning from preclinical studies to clinical applications. Advanced experimental and computational approaches, such as in vitro assays, animal models, molecular modeling, and high-throughput screening, are highlighted to accelerate CNS drug discovery. CNS & Neurological Disorders – Drug Targets is an essential resource for medicinal chemists, pharmacologists, neuroscientists, and clinicians, fostering collaboration between laboratory research and clinical practice. By integrating fundamental and applied research, the journal contributes to the development of safer, more effective, and targeted therapeutics, advancing the treatment of CNS and neurological disorders on a global scale.

CNS & Neurological Disorders - Drug Targets (CNS-NDDT) is :-

• International, Peer-Reviewed, Open Access, Refereed, Molecular targets and drug discovery for CNS diseases, Medicinal chemistry and pharmacology related to neurological disorders, Translational research bridging basic science and clinical applications, Original research articles, reviews, letters, clinical trial studies, Guest‑edited thematic issues by experts in neuroscience and drug targeting , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1871-5273, E-ISSN: 1996-3181, Established: 2006, Impact Factor: 3
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE